Jeunesse Global helps people keep off the pounds with Zen Bodi

Randy Ray and Wendy Lewis are two of the biggest names in the global health and beauty industry. The entrepreneurial power couple first started their own business when they were still in their 20s. By the time they had reached their early 30s, Ray and Lewis had become successful enough that they would never have to work another day in their lives.

Over the next three decades, the couple went on to found and build some of the most successful businesses in the North American health, beauty and direct-marketing industries. When Ray and Lewis found themselves approaching the traditional retirement age, they thought that they would give retirement a try. Unfortunately, the industrious couple found that they simply weren’t constituted for the hours of boredom and idleness that retirement entails. They decided to found a small hobby business out of their garage as a way to pass the time.

Before long, the drive and passion that had marked all of Ray and Lewis’ other pursuits started to shine through with their current business. They soon settled on the trade name Jeunesse Global, and things began picking up steam quickly. By the end of Jeunesse Global’s first year, the company had registered nearly $1 million in sales. By the end of its fifth year, it was doing tens of millions of dollars in sales each year and had thousands of distributors and tens of thousands of customers worldwide.

Now, Jeunesse Global is continuing its tradition of expanding its horizons through great products. With the company’s Zen Bodi, a weight-loss supplement that helps burn fat, build muscle and curb appetite, Jeunesse is making its first entrance into the global weight-loss market.

Like other Jeunesse products, Zen Bodi is not sold using gimmickry or dubious claims. Instead, the supplement and the marketing surrounding it are based 100 percent on rigorous science. Zen Bodi forms part of the larger Zen 8 Project total-health system, which relies heavily on both scientifically engineered supplements as well as the proven methods of behavioral modification.

With Zen Bodi, Jeunesse isn’t promising magic results; it’s providing a biologic rope tow to help motivated users get to the peak of their potential health.

https://www.glassdoor.com/Overview/Working-at-Jeunesse-EI_IE613653.11,19.htm

The Career Journey of Clay Siegall

Clay Siegall is a biomedical expert who continued his studies to tertiary level. Clay got a Ph. D. in Genetics from George Washington University and in the University of Maryland, he received a degree in Bachelor of Science in Zoology. Clay gained experience in his field by working with the National Cancer Institute from 1988 for a period of three years and later joined Bristol-Myers Squibb Pharmaceutical Research Institute the same year. Clay co-founded a biotechnology company known as Seattle Genetics in the year 1998 which was prompted by the fact that he was promoted at the National Cancer Institute. Dr. Clay is currently the head of, the chief executive and also sits on the board as a director of the Seattle Genetics. What this company has on its agenda is to create a platform where drugs are generated that can be used in cancer treatment and boosting the body’s immunity.

Seattle Genetics has introduced cancer therapies that are antibody-based such as ADCETRIS which was permitted by the U.S Food and Drug Administration (FDA) in 2011. ADCETRIS is used by cancer patients around the world because it is easily accessible. The company participates in a platform known as antibody-drug conjugate (ADC) so that exchange of ideas will lead to the development of advanced drugs and encourages cancer patients to use therapy as a procedure of treatment. The incredible achievements of the company have been generated by the mentorship of Clay as he has been in the field for over two decades. Clay Siegall has contributed to the rise of the company’s capital as he has encouraged the participation of the firm in money creating activities and collaborations. Seattle Genetics has collaborated with international companies such as Bayer, Progenics, and MedImmune and this has raised the funds used for research and development of drugs in the corporation.

Dr. Clay is currently participating in different research institutions such as a business alliance known as Fred Hutchinson Cancer Research which mainly target development of drugs used in cancer treatment. In the year 2012, Clay was given the title of the Pacific Northwest Ernst & Young Entrepreneur of the Year because of his determination in ensuring the eradication of cancer in the community.